
Sight Sciences Inc Investor Relations Material
Latest events

Q3 2024
Sight Sciences Inc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Sight Sciences Inc
Access all reports
Sight Sciences, Inc. is a medical technology company focused on developing and commercializing treatments for eye diseases. The company's main business is centered around creating devices that address conditions affecting the eye, particularly in the areas of glaucoma and dry eye disease. Sight Sciences' products are designed to improve patient outcomes by offering minimally invasive solutions that target the underlying causes of these conditions. It serves the ophthalmology and optometry sectors, providing tools for healthcare professionals to enhance the treatment of common but serious eye health issues. The company is headquartered in Menlo Park, California, and its shares are listed on the NASDAQ.
Key slides for Sight Sciences Inc


Q1 2024
Sight Sciences Inc


Q2 2024
Sight Sciences Inc
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
SGHT
Country
🇺🇸 United States